Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 257 articles: HTML format

Single Articles

December 2025
1. BOYER ME, Fleming FJ
   Rethinking Surgical Extent-Long-term Outcomes after Resection of T1 and T2 Colon Cancer.
   Ann Surg Oncol. 2025 Dec 3. doi: 10.1245/s10434-025-18831.
   PubMed    
   
   
   
2. ZHOU Y, Zuo Z, Zhao J, Tan Y, et al
   Development and Validation of Time-to-Event Machine Learning Models for Predicting Disease-Free Survival in Patients with Locally Advanced Colorectal Cancer: A Multicenter Cohort Study.
   Ann Surg Oncol. 2025 Dec 2. doi: 10.1245/s10434-025-18815.
   PubMed     Abstract available
   
   
   
3. MARZI S, Vidiri A, Ianiro A, Parrino C, et al
   CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver Metastases.
   Ann Surg Oncol. 2025;32:9584-9596.
   PubMed     Abstract available
   
   
   
4. SAITO Y, Morine Y, Yamada S, Teraoku H, et al
   Innovative Robotic Liver Resection with Extended Reality for Both Navigation and Medical Education by Three Separate Surgeons.
   Ann Surg Oncol. 2025;32:9630.
   PubMed     Abstract available
   
   
   
5. BOUBADDI M, Pluchon A, Marichez A, Amintas S, et al
   Local Regrowth After a Watch-and-Wait Strategy for Middle and Low Rectal Cancer: Is Organ Preservation Still Feasible?
   Ann Surg Oncol. 2025;32:9502-9509.
   PubMed     Abstract available
   
   
   
6. RAQUEL SG, Cate DWGT, Lopez-Baamonde M, Bojesen RD, et al
   Adherence, Compliance Rates, and Response to Training Among Patients Awaiting Colorectal Cancer Surgery: A Secondary Analysis From the PREHAB Multicentre Trial.
   Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18668.
   PubMed     Abstract available
   
   
   November 2025
7. HOUBIERS A, Barbe R, Durand-Labrunie J, Bani MA, et al
   ASO Author Reflections: Future Role of Radiochemotherapy in the Multimodal Management of Retroperitoneal Lymph Node Metastases From Colorectal Cancer.
   Ann Surg Oncol. 2025 Nov 17. doi: 10.1245/s10434-025-18277.
   PubMed    
   
   
   
8. BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
   Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18696.
   PubMed     Abstract available
   
   
   
9. SCHAFER L, Holzner PA, Menzel M, Stoger GJ, et al
   ASO Visual Abstract: Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.
   Ann Surg Oncol. 2025 Nov 9. doi: 10.1245/s10434-025-18583.
   PubMed    
   
   
   
10. WU Y, Xie Y, Lin J, Cui J, et al
    CD103-Positive Tumor-Infiltrating Lymphocytes Predict a Favorable Prognosis in Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-17977.
    PubMed     Abstract available
    
    
    October 2025
11. SHIMIZU H, Kurashima K, Fukami T, Miyoshi T, et al
    ASO Author Reflections: Glutaredoxin 2 has Potential as a Therapeutic Target for Colon Cancer.
    Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18632.
    PubMed    
    
    
    
12. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
    ASO Visual Abstract: Rurality and Use of Metastasis-Directed Therapies in Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Oct 18. doi: 10.1245/s10434-025-18586.
    PubMed    
    
    
    
13. BRAUNER KB, Mashkoor M, Gogenur M, Lin V, et al
    ASO Visual Abstract: The Association between Conducting a Multidisciplinary Team Conference and Short- and Long-Term Outcomes After Colorectal Cancer Surgery-A National Register Study.
    Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18559.
    PubMed    
    
    
    
14. HOUBIERS A, Barbe R, Durand-Labrunie J, Boige V, et al
    Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis.
    Ann Surg Oncol. 2025 Oct 14. doi: 10.1245/s10434-025-18106.
    PubMed     Abstract available
    
    
    
15. CYR-CRONIER J
    ASO Author Reflections: Radiology Meets Pathology-Identifying the Right Patients for CRS-HIPEC in Colorectal Cancer.
    Ann Surg Oncol. 2025 Oct 12. doi: 10.1245/s10434-025-18523.
    PubMed    
    
    
    
16. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
    ASO Visual Abstract: Adjuvant Chemotherapy and Survival in MSI-High Stage II and III Colon Cancer: Impact of Histopathological Risk Stratification.
    Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18485.
    PubMed    
    
    
    
17. MARINCOLA SMITH P, White MG
    ASO Author Reflections: Role of Repeat Cytoreductive Surgery for Patients with Recurrent Colorectal-Cancer-Related Peritoneal Metastases.
    Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18522.
    PubMed    
    
    
    
18. ERKAYA M, Benlice C, Karahan S, Oruc M, et al
    Adjuvant Chemotherapy and Survival in MSI-High Stages II and III Colon Cancer: Impact of Histopathologic Risk Stratification.
    Ann Surg Oncol. 2025 Oct 7. doi: 10.1245/s10434-025-18285.
    PubMed     Abstract available
    
    
    
19. HEIL J, Sliwinski S, D'Haese J, Fangmann J, et al
    Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry.
    Ann Surg Oncol. 2025;32:7183-7194.
    PubMed     Abstract available
    
    
    
20. CLEMENT E, Alam A, Lange C, Lin W, et al
    The Impact of Multidisciplinary Conference on Clinicians.
    Ann Surg Oncol. 2025;32:7344-7350.
    PubMed     Abstract available
    
    
    
21. APEL R, Sulimani O, Perl G, Abitbol C, et al
    Israel's First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:7200-7208.
    PubMed     Abstract available
    
    
    
22. ABOELMAATY S, Gomaa IA, Sileo A, Sassun R, et al
    The Impact of RAS/BRAF Mutation on Pathological Complete Response After Total Neoadjuvant Therapy in Rectal Cancer.
    Ann Surg Oncol. 2025;32:7326-7332.
    PubMed     Abstract available
    
    
    
23. WANG A, Ying J, Zhang J, Zhu X, et al
    Simultaneous Vaginoplasty with Acellular Dermal Matrix and Pedicled Omental Flap and Pull-Through Colon-Anal Anastomosis for Low Rectal Cancer with Vaginal Invasion.
    Ann Surg Oncol. 2025;32:7351-7352.
    PubMed     Abstract available
    
    
    
24. ZHUANG Z, Yang X, Zhang Y, Deng X, et al
    Discrepancies in the Reactivity of Mesorectal versus Lateral Lymph Nodes Post-Neoadjuvant Chemoradiotherapy for Rectal Cancer: Insights from Radiological and Pathological Perspectives.
    Ann Surg Oncol. 2025;32:7293-7303.
    PubMed     Abstract available
    
    
    
25. LIU A, Reason EH, Sullivan BG, Wildman-Tobriner B, et al
    Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
    Ann Surg Oncol. 2025;32:7131-7140.
    PubMed     Abstract available
    
    
    
26. OCHIAI K, Hida K, Yamaguchi T, Fukuda M, et al
    Risk Factors for and Oncologic Impact of Anastomotic Leakage After Sphincter-Preserving Proctectomy for Mid/Low Rectal Cancer: A Multi-institutional Cohort Study in Japan.
    Ann Surg Oncol. 2025;32:7315-7325.
    PubMed     Abstract available
    
    
    
27. ZHAO J, Zheng P, Xu T, Feng Q, et al
    Preoperative Assessment of Lymph Node Metastasis in Rectal Cancer Using Deep Learning: Investigating the Utility of Various MRI Sequences.
    Ann Surg Oncol. 2025;32:7304-7314.
    PubMed     Abstract available
    
    
    September 2025
28. SCHAFER L, Holzner PA, Menzel M, Stoger GJ, et al
    Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.
    Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18407.
    PubMed     Abstract available
    
    
    
29. BRAUNER KB, Mashkoor M, Gogenur M, Lin V, et al
    The Association Between Conducting a Multidisciplinary Team Conference and Short- and Long-Term Outcomes After Colorectal Cancer Surgery: A National Register Study.
    Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18353.
    PubMed     Abstract available
    
    
    
30. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
    Rurality and Use of Metastasis-Directed Therapies for Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18412.
    PubMed     Abstract available
    
    
    
31. MARINCOLA SMITH P, Lie JJ, Seldomridge A, Galbraith NJ, et al
    Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal Cavity.
    Ann Surg Oncol. 2025 Sep 27. doi: 10.1245/s10434-025-18421.
    PubMed     Abstract available
    
    
    
32. KONG D, Li Y, Yin S, Tan Y, et al
    ASO Visual Abstract: Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Stage II-III Colorectal Cancer Patients.
    Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18368.
    PubMed    
    
    
    
33. OCHIAI K, Bhutiani N
    The Evolving Multidisciplinary Management of Retroperitoneal Lymph Node Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18321.
    PubMed    
    
    
    
34. YANG H, Zeng Q, Zhou Y, Jiang P, et al
    Two Levels of High Ligation of the Inferior Mesenteric Artery Based on Three Anatomical Fasciae for Colorectal Cancer (with Video).
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18224.
    PubMed     Abstract available
    
    
    
35. HOUBIERS A, Barbe R, Durand-Labrunie J, Boige V, et al
    ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18291.
    PubMed    
    
    
    
36. WACH MM, Dineen SP
    ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2025;32:6589-6603.
    PubMed     Abstract available
    
    
    
37. FERNANDEZ M, Todeschini L, Keenan BP, Rosenberg D, et al
    Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-Monocyte Balance in Tumors as a Predictor of Recurrence-Free Survival in Colorectal Carcinoma.
    Ann Surg Oncol. 2025;32:6980-6990.
    PubMed     Abstract available
    
    
    
38. DA SILVA DC, Sousa F, Silva A, Sousa-Pinto B, et al
    Risk Factors for Gastric Cancer in Patients with Lynch Syndrome: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2025;32:6877-6883.
    PubMed     Abstract available
    
    
    
39. VAN GEFFEN EGM, Konishi T, Hazen SJA, Sluckin TC, et al
    Evaluation of Short-Term Postoperative Outcomes of Lateral Lymph Node Dissection After Neoadjuvant Radiotherapy for Rectal Cancer Patients: The Early Learning Phase After Surgical Training in the Netherlands.
    Ann Surg Oncol. 2025;32:6708-6719.
    PubMed     Abstract available
    
    
    
40. SEOW W, Murshed I, Bunjo Z, Bedrikovetski S, et al
    Compliance and Toxicity of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.
    Ann Surg Oncol. 2025;32:6728-6739.
    PubMed     Abstract available
    
    
    
41. KONG D, Li Y, Yin S, Tan Y, et al
    Peritoneal Lavage Cytology Predicts Peritoneal Metastasis and is Associated with Poor Prognosis in Patients with Stage II-III Colorectal Cancer.
    Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18176.
    PubMed     Abstract available
    
    
    August 2025
42. NAKAMICHI N, Shiozaki A, Shimizu H, Otsuji E, et al
    ASO Author Reflections: The Function and Clinical Significance of TRPV2 in Human Colon Cancer.
    Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18228.
    PubMed    
    
    
    
43. CHIU CC, Hsieh MC, Wang GL, Shi HY, et al
    Quality of Life and Minimal Clinically Important Difference in Colorectal Cancer Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy: A Large Prospective Cohort Study.
    Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18147.
    PubMed     Abstract available
    
    
    
44. HANSEN IS, Lappen KR, Brudvik KW, Rosok BI, et al
    A Randomized Controlled Trial of Resection Versus Thermal Ablation of Colorectal Cancer Liver Metastases (New Comet): Study Protocol.
    Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-17984.
    PubMed     Abstract available
    
    
    
45. NIE Y, Kumamoto Y, Yamashita K
    ASO Author Reflections: Cancer Stroma and SPARC are Involved in the Molecular Mechanisms of Poor Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18111.
    PubMed    
    
    
    
46. NIE Y, Fujiyama Y, Shibaki S, Okamoto R, et al
    SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures and CSF1-Mediated Cancer Invasion in Colorectal Cancer.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18039.
    PubMed     Abstract available
    
    
    
47. NAKAMICHI N, Shiozaki A, Kosuga T, Shimizu H, et al
    The Function and Clinical Significance of TRPV2 in Human Colon Cancer.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18083.
    PubMed     Abstract available
    
    
    
48. LIU D, Cai J
    Reply to: "An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer", by Mo et al.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18048.
    PubMed    
    
    
    
49. DE LANGAVANT BC, Kefleyesus A, Peron J, Glehen O, et al
    Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-18022.
    PubMed     Abstract available
    
    
    
50. LABADIE KP, Melstrom LG
    ASO Author Reflections: Optimizing the Dose of Floxuridine for the Adjuvant Treatment of Resected Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-17994.
    PubMed    
    
    
    
51. KATO S, Miyoshi N, Fujino S, Horie M, et al
    ASO Visual Abstract: Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17971.
    PubMed    
    
    
    
52. BADER JM, Ospina A, Liu S, Reddy B, et al
    A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis.
    Ann Surg Oncol. 2025;32:5784-5794.
    PubMed     Abstract available
    
    
    
53. TONELLO M, Cenzi C, Pizzolato E, Martini M, et al
    National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis.
    Ann Surg Oncol. 2025;32:5795-5806.
    PubMed     Abstract available
    
    
    
54. WANG LJ, Bao Q, Wang HW, Huang LF, et al
    Predictive Factors for Chemotherapy Response in Colorectal Liver Metastasis: A Retrospective Study Utilizing Next-Generation Sequencing.
    Ann Surg Oncol. 2025;32:6067-6079.
    PubMed     Abstract available
    
    
    
55. LINDENLAUB F, Asenbaum U, Schwarz C, Makolli J, et al
    Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2025;32:5667-5674.
    PubMed     Abstract available
    
    
    
56. GOHDA Y, Yano H, Suda R, Mirnezami A, et al
    Repeat Diagnostic Laparoscopy After Chemotherapy is Useful in Patient Selection for Conversion to Cytoreductive Surgery for Initially Unresectable Colorectal and Appendiceal Peritoneal Metastases: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025;32:5774-5783.
    PubMed     Abstract available
    
    
    July 2025
57. KATO S, Miyoshi N, Fujino S, Horie M, et al
    Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17765.
    PubMed     Abstract available
    
    
    
58. LABADIE KP, Fan D, Dominguez D, Wong P, et al
    ASO Visual Abstract: Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17928.
    PubMed    
    
    
    
59. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    Reply to: "Concerns Regarding Study Selection and Methodological Rigor in Meta-Analysis on Neoadjuvant Chemotherapy for Colon Cancer".
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17997.
    PubMed    
    
    
    
60. LABADIE KP, Fan D, Dominguez DA, Wong P, et al
    Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17783.
    PubMed     Abstract available
    
    
    
61. NORONHA MM, Leite LF, Peixoto RD
    Concerns Regarding Study Selection and Methodological Rigor in Meta-Analysis on Neoadjuvant Chemotherapy for Colon Cancer.
    Ann Surg Oncol. 2025 Jul 20. doi: 10.1245/s10434-025-17903.
    PubMed    
    
    
    
62. MO Q, Zheng J, Liu C
    Letter to "An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer".
    Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17771.
    PubMed    
    
    
    
63. ZUO D, Wang L, Jin K, Zhang Y, et al
    Genomic and Clinical Predictors of Conversion in Initially Unresectable Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17809.
    PubMed     Abstract available
    
    
    
64. KHALIL M, Pawlik TM
    ASO Author Reflections: The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
    Ann Surg Oncol. 2025 Jul 3. doi: 10.1245/s10434-025-17754.
    PubMed    
    
    
    
65. RAICHURKAR P, Brown KGM, White K, Koh CE, et al
    Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: A Qualitative Exploration of the Lived Experiences of Patients and Carers.
    Ann Surg Oncol. 2025;32:5042-5050.
    PubMed     Abstract available
    
    
    
66. PEREZ RO, Vailati BB, Sao Juliao GP, Mazzucato F, et al
    The Landmark Series: Organ Preservation in Rectal Cancer-The Watch and Wait Strategy.
    Ann Surg Oncol. 2025;32:4945-4956.
    PubMed     Abstract available
    
    
    
67. BUNJO Z, Sammour T
    The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2025;32:4935-4944.
    PubMed     Abstract available
    
    
    
68. ZIVANOV CN, Kau NS, Nalluri-Butz H, Oduyale OK, et al
    Nonoperative Management of Rectal Cancer: Is "Near-Complete" Response Safe to Surveil?
    Ann Surg Oncol. 2025;32:4922-4930.
    PubMed     Abstract available
    
    
    June 2025
69. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363.
    PubMed     Abstract available
    
    
    
70. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    ASO Visual Abstract: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17722.
    PubMed    
    
    
    
71. KHALIL M, Woldesenbet S, Rashid Z, Altaf A, et al
    The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
    Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17711.
    PubMed     Abstract available
    
    
    
72. TODESCHINI L, Hernandez S, Maker AV
    ASO Author Reflections: Precision Immunoprofiling of the Tumor Microenvironment Predicts Recurrence in Advanced Colorectal Cancer.
    Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17728.
    PubMed    
    
    
    
73. SASSUN R, Sileo A, Ng JC
    ASO Author Reflections: Toward a New Standard: The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17677.
    PubMed    
    
    
    
74. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
    Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-Analysis, and Sequential Analysis.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17640.
    PubMed     Abstract available
    
    
    
75. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17404.
    PubMed     Abstract available
    
    
    
76. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    ASO Visual Abstract: Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 Jun 5. doi: 10.1245/s10434-025-17620.
    PubMed    
    
    
    
77. SHIMIZU H, Kurashima K, Fukami T, Shiozaki A, et al
    ASO Visual Abstract: Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
    Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17582.
    PubMed    
    
    
    
78. TAQI K, Icchhpuniani S, Stockley C, Elmi Assadzadeh G, et al
    ASO Visual Abstract: Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS & HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17569.
    PubMed    
    
    
    
79. VAN KESTEREN LJ, Moolenaar LR, Nieuwenhuijzen JA, de Bruijn V, et al
    Double-Barrel Urocolostomy After Pelvic Exenteration: Short-Term Morbidity and Patient-Reported Quality of Life.
    Ann Surg Oncol. 2025;32:4534-4541.
    PubMed     Abstract available
    
    
    
80. JIRATHANIRUANGKIT K, Sainont G, Malakorn S
    Stepwise Approach for Robotic Total Pelvic Exenteration with En Bloc Presacral Fascia in T4b Rectal Cancer.
    Ann Surg Oncol. 2025;32:4250-4251.
    PubMed     Abstract available
    
    
    
81. KIM SJ, Shen C, Moheb ME, Cummins KC, et al
    Sociodemographic Disparities in Rectal Cancer Outcomes within Academic Cancer Centers.
    Ann Surg Oncol. 2025;32:3889-3899.
    PubMed     Abstract available
    
    
    
82. LAPERGOLA A, Melani AG, D'Urso A, Reitano E, et al
    Laparoscopic Oncologic Splenic Flexure Resection: A Complete Mesocolic Excision with Concomitant Inferior Mesenteric Artery and Vein Preservation.
    Ann Surg Oncol. 2025;32:4252-4255.
    PubMed     Abstract available
    
    
    
83. MERKOW RP, Cavnar MJ, Gleisner AL, Mayo SC, et al
    Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective.
    Ann Surg Oncol. 2025;32:4408-4416.
    PubMed     Abstract available
    
    
    May 2025
84. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    ASO Visual Abstract: Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon-Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17469.
    PubMed    
    
    
    
85. TSAGKALIDIS V, Handorf EA, Bates BA, Brauer DG, et al
    Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17486.
    PubMed     Abstract available
    
    
    
86. TAQI K, Icchhpuniani S, Stockley C, Assadzadeh GE, et al
    Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis.
    Ann Surg Oncol. 2025 May 15. doi: 10.1245/s10434-025-17321.
    PubMed     Abstract available
    
    
    
87. BHUTIANI N, Ochiai K, Peacock O, You YN, et al
    Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer.
    Ann Surg Oncol. 2025;32:3098-3105.
    PubMed     Abstract available
    
    
    
88. NG JC, Sileo A, Sassun R, Aboelmaaty S, et al
    Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2025;32:3089-3097.
    PubMed     Abstract available
    
    
    
89. LI ZF, Zhang JN, Tian S, Sun C, et al
    Dual-Time-Point Radiomics for Prognosis Prediction in Colorectal Liver Metastasis Treated with Neoadjuvant Therapy Before Radical Resection: A Two-Center Study.
    Ann Surg Oncol. 2025;32:3516-3525.
    PubMed     Abstract available
    
    
    
90. KAWASHIMA J, Akabane M, Endo Y, Woldesenbet S, et al
    A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size.
    Ann Surg Oncol. 2025;32:3505-3515.
    PubMed     Abstract available
    
    
    
91. GREENSPUN BC, Metzger DA, Foshag A, Marshall TE, et al
    Impact of Delayed Surgery on Local Colorectal Neuroendocrine Tumors: Is Surveillance a Feasible Option?
    Ann Surg Oncol. 2025;32:3112-3118.
    PubMed     Abstract available
    
    
    
92. SCHLEIMER LE, Liu A, Kalvin HL, Barekzai AB, et al
    Robotic Versus Open Placement of Hepatic Artery Infusion Pumps.
    Ann Surg Oncol. 2025;32:3488-3498.
    PubMed     Abstract available
    
    
    
93. ENBLAD M, Cashin P, Ghanipour L, Graf W, et al
    Patterns of Preoperative Tumor Markers Can Predict Resectability and Prognosis of Peritoneal Metastases: A Clustering Analysis.
    Ann Surg Oncol. 2025;32:3638-3647.
    PubMed     Abstract available
    
    
    
94. ZHAN Z, Chen B, Lin W, Chen X, et al
    Rising Burden of Colon and Rectum Cancer in China: An Analysis of Trends, Gender Disparities, and Projections to 2030.
    Ann Surg Oncol. 2025;32:3361-3371.
    PubMed     Abstract available
    
    
    
95. EIKENBOOM EL, Nasar N, Seier K, Gonen M, et al
    Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.
    Ann Surg Oncol. 2025;32:3568-3577.
    PubMed     Abstract available
    
    
    April 2025
96. TAQI K, Mack L, Bouchard-Fortier A
    ASO Authors Reflections: Beyond the Boundaries of Colorectal Cancer Peritoneal and Liver Metastases: Insights from a Systematic Review.
    Ann Surg Oncol. 2025 Apr 29. doi: 10.1245/s10434-025-17395.
    PubMed    
    
    
    
97. LOEHRER AP, Wang Q, O'Malley AJ, Wong SL, et al
    Influence of Medicaid Expansion on Rural Medicare Beneficiaries Undergoing Colon Cancer-Directed Surgery in the United States.
    Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17266.
    PubMed     Abstract available
    
    
    
98. MANGIERI CW, Votanopoulos KI, Shen P, Levine EA, et al
    Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?
    Ann Surg Oncol. 2025;32:2893-2902.
    PubMed     Abstract available
    
    
    
99. WALE A, Harris H, Brown G
    Diagnostic Certainty in Characterizing Liver Lesions in Rectal Cancer: Abbreviated Liver MRI versus CT.
    Ann Surg Oncol. 2025;32:2435-2445.
    PubMed     Abstract available
    
    
    
100. MAKI H, Ayabe RI, Haddad A, Nishioka Y, et al
     Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2025;32:2425-2434.
     PubMed     Abstract available
     
     
     
101. SILEO A, Sassun R, Ng JC, Aboelmaaty S, et al
     Age Matters: Early-Onset Rectal Cancer Exhibits Higher Rates of Pathological Complete Response: A Retrospective Analysis of the Influence of Young Age on Treatment Success in Stage II-III Rectal Cancer.
     Ann Surg Oncol. 2025;32:2302-2307.
     PubMed     Abstract available
     
     
     
102. WANG A, Zhang P, Zang J, Zhang X, et al
     Total Pelvic Exenteration with Presacral Fascia and Pelvic Musculature Excision for Pelvic Recurrence of Rectal Cancer.
     Ann Surg Oncol. 2025;32:2308-2309.
     PubMed     Abstract available
     
     
     
103. COUBEAU L, Foguenne M, Marique L, Bonaccorsi Riani E, et al
     RAPID-Type Auxiliary Liver Transplantation for Unresectable Colorectal Liver Metastases: A First-Stage Surgical Video.
     Ann Surg Oncol. 2025;32:2300-2301.
     PubMed     Abstract available
     
     
     
104. FALLON EA, Awiwi MO, Bhutiani N, Helmink B, et al
     Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis.
     Ann Surg Oncol. 2025;32:2923-2931.
     PubMed     Abstract available
     
     
     
105. GAN Y, Hu Q, Shen Q, Lin P, et al
     Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.
     Ann Surg Oncol. 2025;32:3019-3030.
     PubMed     Abstract available
     
     
     
106. TROESTER A, Weaver L, Mott SL, Welton L, et al
     Patterns of Care and Oncologic Outcomes after Pelvic Exenteration for Locally Advanced Rectal Cancer in the United States.
     Ann Surg Oncol. 2025;32:2271-2281.
     PubMed     Abstract available
     
     
     
107. MOYA-MENDEZ ME, Schaps D, Penvose KN, Chang D, et al
     Weekly Patient-Reported Venous Thromboembolism Prophylaxis Adherence After Colorectal Cancer Surgery.
     Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17267.
     PubMed    
     
     
     March 2025
108. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
     ASO Visual Abstract: Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
     Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17163.
     PubMed    
     
     
     
109. ENGLUM BR, Sahoo S, Mayorga-Carlin M, Siddiqui T, et al
     Disparities in Colorectal Cancer Screening and Diagnoses in the COVID Era: A Study of the VA Health System.
     Ann Surg Oncol. 2025 Mar 20. doi: 10.1245/s10434-025-17153.
     PubMed     Abstract available
     
     
     
110. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
     ASO Visual Abstract: Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
     Ann Surg Oncol. 2025 Mar 3. doi: 10.1245/s10434-025-17071.
     PubMed    
     
     
     
111. KENARY PY, Ross S, Sucandy I
     Robotic Subtotal Caudate Lobe Hepatic Resection for Paracaval Colorectal Metastasis: Technique of Inferior Vena Cava Dissection and Handling.
     Ann Surg Oncol. 2025;32:1769-1770.
     PubMed     Abstract available
     
     
     
112. HADDAD A, Khavandi MM, Lendoire M, Acidi B, et al
     Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration.
     Ann Surg Oncol. 2025;32:1752-1761.
     PubMed     Abstract available
     
     
     
113. KOBAYASHI K, Inoue Y, Oba A, Ono Y, et al
     Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment.
     Ann Surg Oncol. 2025;32:1729-1741.
     PubMed     Abstract available
     
     
     February 2025
114. METZGER D, Greenspun B, Siolas D, Jafari M, et al
     ASO Author Reflections: Risk Stratification Using Genomic Data for Early-Stage Colon Cancer.
     Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17089.
     PubMed    
     
     
     
115. SAMMOUR T
     Invited Editorial: "Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study," by Nozawa et al.
     Ann Surg Oncol. 2025 Feb 26. doi: 10.1245/s10434-025-17044.
     PubMed    
     
     
     
116. DHIMAL T, Fleming FJ
     Neoadjuvant Immunotherapy in Operable Colon Cancer: Opportunities and Challenges.
     Ann Surg Oncol. 2025 Feb 23. doi: 10.1245/s10434-025-17043.
     PubMed    
     
     
     
117. METZGER DA, Greenspun BC, Brouwer J, Li Y, et al
     Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer.
     Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-17014.
     PubMed     Abstract available
     
     
     
118. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
     ASO Author Reflections: Pushing the Boundaries of Local Excision: How Does the Risk of Lymph Node Metastases Compare to Those Associated with Major Surgery in T2 Colon Cancer Patients?
     Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16997.
     PubMed    
     
     
     
119. MI SY, Liao YJ, Kang D, Tang X, et al
     Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer.
     Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16989.
     PubMed     Abstract available
     
     
     
120. SCHLEIMER LE, Hakki L, Seier K, Seo SK, et al
     Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.
     Ann Surg Oncol. 2025;32:1043-1053.
     PubMed     Abstract available
     
     
     
121. LIU A, Lowe M, Niedzwiecki D, Rhodin KE, et al
     Perioperative and Oncologic Outcomes of Hepatic Arterial Infusion (HAI) Pump Chemotherapy for Patients with Unresectable Colorectal Liver Metastases at an Expanding HAI Program.
     Ann Surg Oncol. 2025;32:1033-1042.
     PubMed     Abstract available
     
     
     
122. LIMA DE ARAUJO CA, de Freitas Busnardo F, Thome Grillo VA, Chirnev Felicio CH, et al
     Effect of Early Postoperative Mobilization on Functional Recovery, Hospital Length of Stay, and Postoperative Complications After Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects: A Pr
     Ann Surg Oncol. 2025;32:993-1004.
     PubMed     Abstract available
     
     
     
123. LIU LL, Lin YK, Xiang ZL
     The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
     Ann Surg Oncol. 2025;32:1083-1092.
     PubMed     Abstract available
     
     
     
124. WINICKI NM, Radomski SN, Florissi IS, Wethington S, et al
     Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status: An International Survey of Peritoneal Surface Malignan
     Ann Surg Oncol. 2025;32:671-678.
     PubMed     Abstract available
     
     
     January 2025
125. KANANI A, Veen T, Lea D, Zaharia C, et al
     ASO Visual Abstract: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair-Modelling Oncological Outcomes and Numbers Needed to Treat.
     Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16899.
     PubMed    
     
     
     
126. HANEVELT J, Brohet RM, Moons LMG, Lacle MM, et al
     Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.
     Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16921.
     PubMed     Abstract available
     
     
     
127. KANANI A, Veen T, Lea D, Zaharia C, et al
     Correction: Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
     Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-025-16888.
     PubMed    
     
     
     
128. TIDADINI F, Arvieux C, Glehen O, Sourrouille I, et al
     Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.
     Ann Surg Oncol. 2025;32:209-220.
     PubMed     Abstract available
     
     
     
129. MATHEW J, Kazi M, Desouza A, Saklani A, et al
     Postoperative Morbidity and Factors Predicting the Development of Lymphoceles Following Lateral Pelvic Node Dissection for Rectal Cancer: A Cohort Study.
     Ann Surg Oncol. 2025;32:165-175.
     PubMed     Abstract available
     
     
     
130. FEFERMAN Y, Verheij FS, Williams H, Omer DM, et al
     Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection.
     Ann Surg Oncol. 2025;32:128-136.
     PubMed     Abstract available
     
     
     
131. SASAKI K, Wang J, Kamphues C, Buettner S, et al
     Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study.
     Ann Surg Oncol. 2025;32:408-417.
     PubMed     Abstract available
     
     
     
132. MURSHED I, Bunjo Z, Seow W, Murshed I, et al
     Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.
     Ann Surg Oncol. 2025;32:137-157.
     PubMed     Abstract available
     
     
     December 2024
133. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
     ASO Visual Abstract: Disparities in Palliative Treatment Utilization in Patients with Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2024 Dec 31. doi: 10.1245/s10434-024-16749.
     PubMed    
     
     
     
134. AREZO K, Torhild V, Dordi L, Claudia Z, et al
     Neoadjuvant Immunotherapy Followed by Surgery Compared with Upfront Surgery Alone in Operable Colon Cancer with Deficient Mismatch Repair: Modeling Oncological Outcomes and Numbers Needed to Treat.
     Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16755.
     PubMed     Abstract available
     
     
     
135. EL MOHEB M, Shen C, Kim S, Putman K, et al
     ASO Visual Abstract: Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
     Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16695.
     PubMed    
     
     
     
136. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
     ASO Visual Abstract: Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregula
     Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16750.
     PubMed    
     
     
     
137. ZHENG J, Wang T, Wang H, Yan B, et al
     ASO Visual Abstract: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
     Ann Surg Oncol. 2024 Dec 26. doi: 10.1245/s10434-024-16680.
     PubMed    
     
     
     
138. MOHEB ME, Tsung A
     ASO Author Reflections: Decoding Racial Differences in Colon Cancer Transcriptomes.
     Ann Surg Oncol. 2024 Dec 7. doi: 10.1245/s10434-024-16682.
     PubMed    
     
     
     
139. PATEL DD, Dickson PV
     Invited Editorial About: "Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer," by C. Komine et al.
     Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16609.
     PubMed    
     
     
     
140. QIN Y, Miyake T, Muramoto K, Maekawa T, et al
     Fibroblast Activation Protein-alpha Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survi
     Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16593.
     PubMed     Abstract available
     
     
     
141. KARAGKOUNIS G, Horvat N, Danilova S, Chhabra S, et al
     Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After Chemotherapy.
     Ann Surg Oncol. 2024;31:9196-9204.
     PubMed     Abstract available
     
     
     
142. RISBEY CWG, Brown KGM, Solomon M, McBride K, et al
     Cost Analysis of Pelvic Exenteration Surgery for Advanced Pelvic Malignancy.
     Ann Surg Oncol. 2024;31:9079-9087.
     PubMed     Abstract available
     
     
     
143. PALMIERI L, Santullo F, Lodoli C, Certelli C, et al
     Robotic Recto-Sigmoid Resection with Total Intracorporeal Colorectal Anastomosis (TICA) in Recurrent Ovarian Cancer.
     Ann Surg Oncol. 2024;31:8952-8953.
     PubMed     Abstract available
     
     
     
144. ALLIEVI N, Sidhom M, Samuel MV, Tzivanakis A, et al
     Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
     Ann Surg Oncol. 2024;31:8585-8595.
     PubMed     Abstract available
     
     
     November 2024
145. ZHENG J, Wang T, Wang H, Yan B, et al
     Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
     Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16519.
     PubMed     Abstract available
     
     
     
146. LIU D, Chen Z, Deng W, Lan J, et al
     ASO Visual Abstract: An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
     Ann Surg Oncol. 2024 Nov 29. doi: 10.1245/s10434-024-16599.
     PubMed    
     
     
     
147. LIU D, Chen Z, Deng W, Lan J, et al
     An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
     Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16469.
     PubMed     Abstract available
     
     
     
148. EL MOHEB M, Shen C, Kim S, Putman K, et al
     Stage-Specific Tumoral Gene Expression Profiles of Black and White Patients with Colon Cancer.
     Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16550.
     PubMed     Abstract available
     
     
     
149. SEDIGHIM S, Khorfan R, Shin J, Khan A, et al
     Disparities in Palliative Treatment Utilization in Metastatic Colorectal Cancer Patients.
     Ann Surg Oncol. 2024 Nov 22. doi: 10.1245/s10434-024-16577.
     PubMed     Abstract available
     
     
     
150. KHORFAN R, Sedighim S, Caba-Molina D, Tran TB, et al
     National Trends and Outcomes in Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases Before and After PRODIGE 7.
     Ann Surg Oncol. 2024 Nov 21. doi: 10.1245/s10434-024-16539.
     PubMed    
     
     
     
151. MEN V, Jin JZ
     ASO Author Reflections: Lymph Node Yield and Long-Term Survival in Colon Cancer-Insights from a 20-Year National Study.
     Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16565.
     PubMed    
     
     
     
152. LIU D, Yang K, Cai J
     ASO Author Reflections: Organoid Model to Aid the Decision of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
     Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16555.
     PubMed    
     
     
     
153. ZHENG J, Wang T, Wang S, Ji H, et al
     ASO Author Reflections: Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.
     Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16576.
     PubMed    
     
     
     
154. MEN V, Bahl P, Jin JZ, Singh PP, et al
     ASO Visual Abstract: Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
     Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16513.
     PubMed    
     
     
     
155. NOZAWA H, Ito S, Sasaki K, Murono K, et al
     Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer-A Multicenter Retrospective Study.
     Ann Surg Oncol. 2024 Nov 18. doi: 10.1245/s10434-024-16537.
     PubMed     Abstract available
     
     
     
156. HADDAD A, Lendoire M, Uppal A, Maki H, et al
     CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases.
     Ann Surg Oncol. 2024 Nov 8. doi: 10.1245/s10434-024-16370.
     PubMed     Abstract available
     
     
     
157. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
     ASO Visual Abstract: Clinical Outcomes, Costs, and Value of Undergoing Surgery Among Older Patients with Colon Cancer at U.S. News & World Report Ranked Versus Unranked Hospitals.
     Ann Surg Oncol. 2024 Nov 6. doi: 10.1245/s10434-024-16406.
     PubMed    
     
     
     
158. MEN V, Bahl P, Jin JZ, Singh PP, et al
     Lymph Node Yield and Long-Term Mortality Risk in Patients with Colon Cancer: A 20-Year Follow-Up National Study.
     Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16428.
     PubMed     Abstract available
     
     
     
159. ZHANG H, Zhuo C, Lin R, Ke F, et al
     ASO Author Reflections: Why are the Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases so Important?
     Ann Surg Oncol. 2024 Nov 4. doi: 10.1245/s10434-024-16334.
     PubMed    
     
     
     
160. WAHEED MT, Ruel N, Whelan RL, Fakih M, et al
     Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial.
     Ann Surg Oncol. 2024;31:7998-8007.
     PubMed     Abstract available
     
     
     
161. KAWADA K, Inamura Y, Morikawa A, Matsuoka H, et al
     Perineal-First Approach in Robotic Abdominoperineal Resection.
     Ann Surg Oncol. 2024;31:7820-7821.
     PubMed     Abstract available
     
     
     
162. WANG A, Wang A, Xu X, Chen M, et al
     ASO Author Reflections: Simultaneous Robotic Surgery for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
     Ann Surg Oncol. 2024;31:7852-7853.
     PubMed    
     
     
     
163. HILTY CHU BK, Loria A, Dhimal T, Cupertino P, et al
     ASO Author Reflections: Improving Shared-Decision Making in Rectal Cancer.
     Ann Surg Oncol. 2024;31:7856-7857.
     PubMed    
     
     
     
164. HILTY CHU BK, Loria A, Dhimal T, Li Y, et al
     The Rise of Patients Declining Rectal Cancer Surgery in the Era of Total Neoadjuvant Therapy.
     Ann Surg Oncol. 2024;31:7798-7806.
     PubMed     Abstract available
     
     
     
165. BROWN KGM, Solomon MJ
     Understanding Quality of Life After Pelvic Exenteration for Patients with Rectal Cancer.
     Ann Surg Oncol. 2024;31:7668-7670.
     PubMed    
     
     
     
166. WANG A, Wang A, Xu X, Chen M, et al
     Simultaneous Robotic Sphincter-Preserving Rectal Resection and Prostatectomy for Rectal Gastrointestinal Stromal Tumor and Prostatic Cancer.
     Ann Surg Oncol. 2024;31:7796-7797.
     PubMed     Abstract available
     
     
     October 2024
167. KIM SJ, Park MY, Yang SY, Han YD, et al
     ASO Visual Abstract: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
     Ann Surg Oncol. 2024 Oct 10. doi: 10.1245/s10434-024-16280.
     PubMed    
     
     
     
168. ZHANG H, Zhuo C, Lin R, Ke F, et al
     Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases Through Analysis of Single-Cell Sequencing Data and TCGA Data.
     Ann Surg Oncol. 2024 Oct 9. doi: 10.1245/s10434-024-16194.
     PubMed     Abstract available
     
     
     
169. STEPHENS KR, Donica WRF, Egger ME, Philips P, et al
     Observed Changes in the Distribution of Colon Cancer Metastasis: A National Cancer Database Review and Institutional Experience.
     Ann Surg Oncol. 2024 Oct 8. doi: 10.1245/s10434-024-16330.
     PubMed     Abstract available
     
     
     
170. DOSSA F, Weiser MR
     Omission of Radiotherapy for Locally Advanced Rectal Cancer: A Step Toward Patient-Centric Treatment Decision-Making.
     Ann Surg Oncol. 2024;31:6337-6341.
     PubMed    
     
     
     
171. WEAVER L, Goffredo P
     ASO Author Reflections: Malignant Colon Polyps-Is Tumor Laterality the New Black?
     Ann Surg Oncol. 2024;31:6472-6473.
     PubMed    
     
     
     
172. WEAVER L, Boatman S, Kohn J, Mott SL, et al
     The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps.
     Ann Surg Oncol. 2024;31:6452-6460.
     PubMed     Abstract available
     
     
     
173. JEONG MH, Kang SJ, Park SY, Kwak SG, et al
     Comparison of EPIC Versus HIPEC in the Treatment of Colorectal Peritoneal Metastases and Appendix Tumors Using Inverse Probability of Treatment Weighting.
     Ann Surg Oncol. 2024;31:7111-7121.
     PubMed     Abstract available
     
     
     
174. SCHWANTES IR, Patel RK, Kardosh A, Paxton J, et al
     A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
     Ann Surg Oncol. 2024;31:6537-6545.
     PubMed     Abstract available
     
     
     
175. GLYNNE-JONES R
     Editorial: "Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer," by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World.
     Ann Surg Oncol. 2024;31:6344-6347.
     PubMed    
     
     
     
176. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
     Pathologic Complete Response, Total Neoadjuvant Therapy and the Survival Paradox in Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2024;31:6432-6442.
     PubMed     Abstract available
     
     
     
177. TROESTER A, Hassan I, Goffredo P
     ASO Author Reflections: Not All pCRs are Created Equal in Rectal Cancer.
     Ann Surg Oncol. 2024;31:6470-6471.
     PubMed    
     
     
     
178. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
     Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
     Ann Surg Oncol. 2024;31:6443-6451.
     PubMed     Abstract available
     
     
     September 2024
179. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
     Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
     Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16195.
     PubMed     Abstract available
     
     
     
180. KOMINE C, Sohda M, Yokobori T, Shioi I, et al
     ASO Visual Abstract: Impact of Tumoral beta2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
     Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16285.
     PubMed    
     
     
     
181. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
     ASO Visual Abstract: Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer-A Matched Pair Analysis.
     Ann Surg Oncol. 2024 Sep 26. doi: 10.1245/s10434-024-16271.
     PubMed    
     
     
     
182. ALTAF A, Pawlik TM
     ASO Author Reflections: Clinical Outcomes, Costs, and Value of Undergoing Surgery among Older Patients with Colon Cancer at U.S. News & World Report Ranked versus Unranked Hospitals.
     Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16274.
     PubMed    
     
     
     
183. KIM SJ, Park MY, Yang SY, Han YD, et al
     Minimally Invasive Surgery: Is It a Risk Factor for Postoperative Peritoneal Metastasis in pT4 Colon Cancer?
     Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16177.
     PubMed     Abstract available
     
     
     
184. ALTAF A, Woldesenbet S, Munir MM, Khan MMM, et al
     Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with Colon Cancer at US News and World Report Ranked Versus Unranked Hospitals.
     Ann Surg Oncol. 2024 Sep 14. doi: 10.1245/s10434-024-16217.
     PubMed     Abstract available
     
     
     
185. KOBAYASHI K, Toritani K, Kimura H, Kawashima J, et al
     Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis.
     Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16158.
     PubMed     Abstract available
     
     
     
186. YU AT, Hanna DN, Li TM, Sarfaty E, et al
     Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor Outcomes.
     Ann Surg Oncol. 2024;31:6252-6261.
     PubMed     Abstract available
     
     
     
187. LEITAO MM JR, Weiser MR, Mueller JJ
     Uterine Anastomosis with Low Anterior Resection.
     Ann Surg Oncol. 2024;31:6048.
     PubMed     Abstract available
     
     
     
188. GOFFREDO P, Suraju MO, Mott SL, Troester AM, et al
     ASO Visual Abstract: Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2024;31:5971-5972.
     PubMed    
     
     
     
189. DOROUDIAN S, Osterman E, Glimelius B
     Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort.
     Ann Surg Oncol. 2024;31:5570-5584.
     PubMed     Abstract available
     
     
     
190. SADAMORI H, Monden K, Hioki M, Iwasaki H, et al
     Liver Resection Under Total Hepatic Vascular Exclusion with In Situ Hypothermic Isolated Hepatic Perfusion for Advanced Liver Tumors.
     Ann Surg Oncol. 2024;31:5638-5639.
     PubMed     Abstract available
     
     
     
191. NOIRET B, Piessen G, Eveno C
     ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways.
     Ann Surg Oncol. 2024;31:6274-6275.
     PubMed    
     
     
     
192. NOIRET B, Lenne X, Bruandet A, Piessen G, et al
     Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.
     Ann Surg Oncol. 2024;31:6220-6227.
     PubMed     Abstract available
     
     
     August 2024
193. CO LMB, Dychiao RGK, Capistrano MPR, Tayag MT, et al
     Identifying Gaps in Early-Onset Colorectal Cancer Prevention, Screening, and Treatment in the Philippines.
     Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16038.
     PubMed    
     
     
     
194. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
     ASO Visual Abstract: Accuracy of Clinical Staging of Localized Colon Cancer-A National Cancer Database Cohort Analysis.
     Ann Surg Oncol. 2024 Aug 21. doi: 10.1245/s10434-024-16101.
     PubMed    
     
     
     
195. REITZ ACW, Massarweh NN
     Preoperative Staging of Colon Cancer-Picking the Lesser of Two Evils.
     Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-16052.
     PubMed    
     
     
     
196. CHEN M, Deng S, Cao Y, Wang J, et al
     ASO Visual Abstract: Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
     Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15989.
     PubMed    
     
     
     
197. STEFFENS D, Nott F, Koh C, Jiang W, et al
     ASO Visual Abstract: Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
     Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-15978.
     PubMed    
     
     
     
198. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
     ASO Visual Abstract: Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
     Ann Surg Oncol. 2024;31:5002-5003.
     PubMed    
     
     
     
199. NABATA KJ, Rai S, Zhao D, MacNeill AJ, et al
     ASO Visual Abstract: Negative Pressure Wound Therapy to Reduce Surgical Site Infections After CRS/HIPEC.
     Ann Surg Oncol. 2024;31:5219.
     PubMed    
     
     
     
200. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
     ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.
     Ann Surg Oncol. 2024;31:5400-5401.
     PubMed    
     
     
     
201. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
     ASO Visual Abstract: Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients Who Undergo Resection for Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:5217-5218.
     PubMed    
     
     
     July 2024
202. EMILE SH, Wexner SD
     ASO Author Reflections: Clinical Staging of Localized Colon Cancer: Room for Improvement.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15956.
     PubMed    
     
     
     
203. EMILE SH, Horesh N, Garoufalia Z, Dourado J, et al
     Accuracy of Clinical Staging of Localized Colon Cancer: A National Cancer Database Cohort Analysis.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15875.
     PubMed     Abstract available
     
     
     
204. CHEN M, Deng S, Cao Y, Huang L, et al
     ASO Author Reflections: Stage II/III Colorectal Cancer Patients with Mismatch Repair Deficiency Need More Personalized Adjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15926.
     PubMed    
     
     
     
205. NEE K, Hosohama L, Alobuia W, Kim AC, et al
     Defining Colorectal Cancer Cells on a Single Cell Level Reveals LGR5+ Proliferative Stem Cell Expression in Peritoneal Metastasis.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15783.
     PubMed    
     
     
     
206. ROXBURGH CS
     Time to Change Strategy in Non-metastatic Locally Advanced Mismatch Repair-Deficient Colon Cancer.
     Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15780.
     PubMed    
     
     
     
207. STEFFENS D, Solomon MJ, Jack S, West MA, et al
     ASO Author Reflections: Improving Postoperative Outcomes in Colorectal Cancer Surgery: Where are We with Prehabilitation?
     Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15835.
     PubMed    
     
     
     
208. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
     ASO Visual Abstract: The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer-A Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15747.
     PubMed    
     
     
     
209. CHEN M, Deng S, Cao Y, Wang J, et al
     Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15759.
     PubMed     Abstract available
     
     
     
210. LIN X, Haiyang Z
     Patient-Reported Outcomes in Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer After Pelvic Exenteration.
     Ann Surg Oncol. 2024 Jul 9. doi: 10.1245/s10434-024-15722.
     PubMed     Abstract available
     
     
     
211. LIN X, Haiyang Z
     ASO Author Reflections: Pelvic Exenteration for Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer: A Report of 122 Cases.
     Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15782.
     PubMed    
     
     
     
212. AYABE RI, Beaty K, Newhook TE, Cao HST, et al
     Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer.
     Ann Surg Oncol. 2024 Jul 6. doi: 10.1245/s10434-024-15694.
     PubMed    
     
     
     
213. JANCZEWSKI LM, Asare EA, Goodman KA
     Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.
     Ann Surg Oncol. 2024;31:4155-4158.
     PubMed    
     
     
     
214. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
     ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
     Ann Surg Oncol. 2024;31:4466-4467.
     PubMed    
     
     
     
215. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
     Ann Surg Oncol. 2024;31:4749-4750.
     PubMed    
     
     
     
216. SHAPERA E, Ross S, Pattilachan T, Christodoulou M, et al
     Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
     Ann Surg Oncol. 2024;31:4449-4451.
     PubMed     Abstract available
     
     
     
217. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
     Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:4436-4444.
     PubMed     Abstract available
     
     
     
218. EL ASMAR A, Kamdem L, Khaled C, Liberale G, et al
     ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.
     Ann Surg Oncol. 2024;31:4558-4559.
     PubMed    
     
     
     
219. BLANCO ASENSIO N, Aliseda Jover D, Marti-Cruchaga P, Lapuente F, et al
     Anatomical Left Hepatectomy Extended to Caudate Lobe due to Colorectal Metastasis with Intrabiliary Growth: Securing Optimal Margins with a Laennec's Capsule Approach and Vein-Guided Resection.
     Ann Surg Oncol. 2024;31:4447-4448.
     PubMed    
     
     
     
220. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
     Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
     Ann Surg Oncol. 2024;31:4339-4348.
     PubMed     Abstract available
     
     
     
221. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
     Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
     Ann Surg Oncol. 2024;31:4413-4426.
     PubMed     Abstract available
     
     
     June 2024
222. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
     ASO Visual Abstract: Para-aortic Lymph Node Dissection for Colorectal Cancer-Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
     Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15690.
     PubMed    
     
     
     
223. STEFFENS D, Nott F, Koh C, Jiang W, et al
     Effectiveness of Prehabilitation Modalities on Postoperative Outcomes Following Colorectal Cancer Surgery: A Systematic Review of Randomised Controlled Trials.
     Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15593.
     PubMed     Abstract available
     
     
     
224. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
     The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Jun 21. doi: 10.1245/s10434-024-15595.
     PubMed     Abstract available
     
     
     
225. BHUTIANI N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, et al
     Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.
     Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15539.
     PubMed     Abstract available
     
     
     
226. SHIN JK, Kim HC
     ASO Author Reflections: Robotic Surgery is Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy.
     Ann Surg Oncol. 2024;31:3959-3960.
     PubMed    
     
     
     
227. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     ASO Author Reflections: Addressing Hospital-Based Disparities in Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) and Survival in Patients with Isolated Colorectal Peritoneal Metastases.
     Ann Surg Oncol. 2024;31:3787-3788.
     PubMed    
     
     
     
228. KAMDEM L, Asmar AE, Demetter P, Zana IC, et al
     Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
     Ann Surg Oncol. 2024;31:3778-3784.
     PubMed     Abstract available
     
     
     
229. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
     Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
     Ann Surg Oncol. 2024;31:3758-3768.
     PubMed     Abstract available
     
     
     
230. PIKOULIS E, Beyer K, Kreis ME, Pawlik TM, et al
     ASO Author Reflections: Surgical Technique for Colorectal Liver Metastases: Biology is King, but the Princes and Princesses (Surgical Techniques) also Matter.
     Ann Surg Oncol. 2024;31:4046-4047.
     PubMed    
     
     
     May 2024
231. HUANG Y, Liao F, Chen H, Shu X, et al
     ASO Author Reflections: Self-expanding Metal Stents for Right-Sided Colonic Cancer Obstruction.
     Ann Surg Oncol. 2024;31:3242-3243.
     PubMed    
     
     
     
232. GOMAA I, Aboelmaaty S, Narasimhan AL, Bhatt H, et al
     The Impact of Enhanced Recovery on Long-Term Survival in Rectal Cancer.
     Ann Surg Oncol. 2024;31:3233-3241.
     PubMed     Abstract available
     
     
     
233. ONO Y, Inoue Y, Ito H, Takahashi Y, et al
     ASO Author Reflections: Advancing Two-Stage Hepatectomy: Laparoscopic Portal Vein Ligation and Embolization for Initially Unresectable Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:3114-3115.
     PubMed    
     
     
     
234. HUANG Y, Liao F, Zhan Z, Chen X, et al
     Efficacy and Safety Analysis of Emergency Endoscopic Self-Expanding Metal Stent Placement Without Fluoroscopic Assistance for Right-Sided Colonic Cancer Obstruction.
     Ann Surg Oncol. 2024;31:3212-3221.
     PubMed     Abstract available
     
     
     
235. GORJI L, Nikahd M, Onuma A, Tsilimigras D, et al
     Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
     Ann Surg Oncol. 2024;31:3389-3396.
     PubMed     Abstract available
     
     
     
236. SHIN JK, Kim HC, Lee WY, Yun SH, et al
     Is Robotic Surgery Beneficial for Rectal Cancer Patients with Unfavorable Characteristic After Neoadjuvant Chemoradiotherapy?
     Ann Surg Oncol. 2024;31:3203-3211.
     PubMed     Abstract available
     
     
     
237. FACKCHE NT, Schmocker RK, Nudotor R, Kubi B, et al
     Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
     Ann Surg Oncol. 2024;31:3314-3324.
     PubMed     Abstract available
     
     
     
238. ONO Y, Inoue Y, Kobayashi K, Sato S, et al
     Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:3069-3070.
     PubMed     Abstract available
     
     
     April 2024
239. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
     Disparities in Colorectal Cancer Screening.
     Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.
     PubMed    
     
     
     
240. BEKKI T, Shimomura M, Yano T, Akabane S, et al
     Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
     Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.
     PubMed    
     
     
     
241. KHAN MMM, Munir MM, Khalil M, Pawlik TM, et al
     Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic.
     Ann Surg Oncol. 2024 Apr 23. doi: 10.1245/s10434-024-15302.
     PubMed    
     
     
     
242. YANG Y, Du Z, Zhang Q
     Letter to Editor regarding article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
     Ann Surg Oncol. 2024 Apr 10. doi: 10.1245/s10434-024-15263.
     PubMed    
     
     
     
243. BOYEV A, Newhook TE
     ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
     Ann Surg Oncol. 2024;31:2600-2601.
     PubMed    
     
     
     
244. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
     ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
     Ann Surg Oncol. 2024;31:2598-2599.
     PubMed    
     
     
     
245. CHOI JS, Kim MJ, Shin R, Park JW, et al
     ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
     Ann Surg Oncol. 2024;31:2439.
     PubMed    
     
     
     
246. WACH MM, Nunns G, Hamed A, Derby J, et al
     Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
     Ann Surg Oncol. 2024;31:2391-2400.
     PubMed     Abstract available
     
     
     
247. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
     Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
     Ann Surg Oncol. 2024;31:2425-2438.
     PubMed     Abstract available
     
     
     
248. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
     ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:2606.
     PubMed    
     
     
     
249. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
     Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
     Ann Surg Oncol. 2024;31:2408-2409.
     PubMed    
     
     
     
250. HIRST N, McBride K, Steffens D
     Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
     Ann Surg Oncol. 2024;31:2183-2186.
     PubMed    
     
     
     
251. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
     ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
     Ann Surg Oncol. 2024;31:2440-2441.
     PubMed    
     
     
     
252. CHOI JS, Kim MJ, Shin R, Park JW, et al
     Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
     Ann Surg Oncol. 2024;31:2414-2424.
     PubMed     Abstract available
     
     
     
253. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
     Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2024;31:2547-2556.
     PubMed     Abstract available
     
     
     
254. CHIU CC
     Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
     Ann Surg Oncol. 2024;31:2405-2407.
     PubMed    
     
     
     March 2024
255. KHAN MMM, Munir MM, Woldesenbet S, Endo Y, et al
     ASO Visual Abstract: Association of COVID-19 Pandemic with Colorectal Cancer Screening: Impact of Race/Ethnicity and Social Vulnerability.
     Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15140.
     PubMed    
     
     
     November 2023
256. SOLBAKKEN AM, Sellevold S, Spasojevic M, Julsrud L, et al
     Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer.
     Ann Surg Oncol. 2023;30:7602-7611.
     PubMed     Abstract available
     
     
     
257. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
     Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
     Ann Surg Oncol. 2023;30:7362-7370.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.